Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Livzon Pharmaceutical Group


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
The average size of a deal this fund participated in
Portfolio companies 5
Rounds per year 0.22
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Life Science

Livzon Pharmaceutical Group appeared to be the Corporate Investor, which was created in 1985. The main office of represented Corporate Investor is situated in the Zhuhai. The fund was located in Asia if to be more exact in China.

Among the most popular fund investment industries, there are Medical, Health Diagnostics. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Elicio Therapeutics, Cynvenio Biosystems. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Syno Capital, Greenwoods Asset Management, EFung Capital.

The important activity for fund was in 2015. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Livzon Pharmaceutical Group:
Typical Co-investors
Livzon Pharmaceutical Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Livzon Pharmaceutical Group:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alfa Ventures Delhi, Delhi, India
Almeda Ventures Israel, Tel Aviv, Tel Aviv District
Ann Arbor Angels Ann Arbor, Michigan, United States
DoubleLine Equity Healthcare Fund -
Huihua Investment China, Fenghua, Zhejiang
Korea Thrunet Co Seoul, Seoul-t'ukpyolsi, South Korea
Lan Fund Beijing, Beijing, China
Lianhe Zhongan Wenhua Beijing, China, Haidian
Milestone Capital Partners England, London, United Kingdom
Qianshan Capital Chaoyang, China, Liaoning
Qicheng Chuang Tou China, Dongguan, Hebei
Quintus Vermoegensverwaltung GmbH -
Resolute Ventures California, San Francisco, United States
Saracen Ventures -
Shenzhen Shi Qianhai Dingdian Jinrong China, Guangdong, Shenzhen
Startup:Education New Jersey, Newark, United States
Stokke Industri -
Thurston Group Chicago, Illinois, United States
Viscogliosi Brothers New York, New York, United States
Westcott LLC Dallas, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Carisma Therapeutics

Health Care
Life Science
$30M21 Sep 2022 Philadelphia, Pennsylvania, United States

Atom Bioscience & Pharmaceutical

Drug Discovery
Health Care
$45M05 Jan 2022 Zhenjiang, Guangdong Province, China

Carisma Therapeutics

Health Care
Life Science
$12M01 Mar 2021 Philadelphia, Pennsylvania, United States

Carisma Therapeutics

Health Care
Life Science
$47M07 Jan 2021 Philadelphia, Pennsylvania, United States

Atom Bioscience & Pharmaceutical

Drug Discovery
Health Care
$30M27 May 2020 Guangdong Province

Elicio Therapeutics

Health Care
$33M02 Oct 2019 Cambridge, Massachusetts, United States

Livzon Mabpharm

Health Care
27 Jun 2018 Xiangzhou District, Guangdong Province, China

LungLife AI

Artificial Intelligence
Health Diagnostics
Machine Learning
$25M17 Jun 2015 California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Livzon Pharmaceutical Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: